ScholarIQanswers from OpenAlex & ORCID
Marvin Bergsneider
ResearcherPublications, citations & collaboration network
Marvin Bergsneider is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Marvin Bergsneider have?
ScholarIQindexed works
Marvin Bergsneider has 343 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Marvin Bergsneider have?
ScholarIQcitation count
Marvin Bergsneider has 12,687 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Marvin Bergsneider?
ScholarIQh-index
Marvin Bergsneider has an h-index of 52 in OpenAlex.
What is the i10-index of Marvin Bergsneider?
ScholarIQi10-index
Marvin Bergsneider has an i10-index of 142 in OpenAlex.
What is the OpenAlex record for Marvin Bergsneider?
ScholarIQopenalex
The OpenAlex for Marvin Bergsneider is on the source record.
What are the most-cited papers on Marvin Bergsneider?
ScholarIQmost cited works
Diagnosing Idiopathic Normal-pressure Hydrocephalus
Norman Relkin, Anthony Marmarou, Petra M. Klinge, Marvin Bergsneider, Peter McL. Black
Cerebral hyperglycolysis following severe traumatic brain injury in humans: a positron emission tomography study
Marvin Bergsneider, David A. Hovda, Ehud Shalmon, Daniel F. Kelly, Paul Vespa, Neil A. Martin, Michael E. Phelps, David L. McArthur, Michael Caron, Jess F. Kraus, Donald P. Becker
Metabolic Crisis without Brain Ischemia is Common after Traumatic Brain Injury: A Combined Microdialysis and Positron Emission Tomography Study
Paul Vespa, Marvin Bergsneider, Nayoa Hattori, Hsiao-Ming Wu, Sung‐Cheng Huang, Neil A. Martin, Thomas C. Glenn, David L. McArthur, David A. Hovda
Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring
Paul Vespa, Marc R. Nuwer, Valeriy Nenov, Elisabeth Ronne-Engström, David A. Hovda, Marvin Bergsneider, Daniel F. Kelly, Neil A. Martin, Donald P. Becker
Antitumor Activity of Rapamycin in a Phase I Trial for Patients with Recurrent PTEN-Deficient Glioblastoma
Tim Cloughesy, Koji Yoshimoto, Phioanh L. Nghiemphu, Kevin R. Brown, Julie Dang, Shaojun Zhu, Teli Hsueh, Yinan Chen, Wei Wang, David Youngkin, Linda M. Liau, Neil A. Martin, Don Becker, Marvin Bergsneider, Albert Lai, Richard Green, Tom Oglesby, Michael Koleto, J.M. Trent, Steve Horvath, Paul S. Mischel, Ingo K. Mellinghoff, Charles L. Sawyers